Syndax Pharmaceuticals Inc (SNDX)

Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.44%83.30	72.79	64.86	68.73	45.87
	11.00%125.19	112.78	99.07	131.28	103.30
Research and Development	0.82%67.48	68.04	58.85	78.64	56.28
Operating Income/Loss	4.75%-41.90	-40.00	-34.20	-62.55	-57.43
Nonoperating Income/Loss	19.53%-7.54	-9.37	-8.47	-5.47	-3.29
Income Tax Expense/Benefit	-	-	-	0.43	-
	0.14%-49.43	-49.36	-42.67	-68.01	-60.72
Attributable To Parent	0.14%-49.43	-49.36	-42.67	-68.01	-60.72
Available To Common Stockholders, Basic	0.14%-49.43	-49.36	-42.67	-68.01	-60.72
Basic Average Shares	0.90%89.79	88.99	88.26	0.09	86.62
Diluted Average Shares	0.90%89.79	88.99	88.26	0.09	86.62
Basic Earnings Per Share	-0.55	-0.55	-0.48	-0.78	-0.70
Diluted Earnings Per Share	-0.55	-0.55	-0.48	-0.78	-0.70